Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 5 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT07199972Completed

COVID-Related Tinnitus Timeline

Role: lead

NCT01333683Unknown

Tinnitus and Arterial Hypertension

Role: lead

NCT00628316Not ApplicableCompleted

Effects of Caffeine in Tinnitus

Role: lead

NCT01187251Completed

Incidence of Tinnitus Amongst Teenagers and Young Adults mp3 Users

Role: lead

NCT00976547Completed

Correlation Analysis of Hearing Thresholds, Validated Questionnaires and Psychoacoustic Measurements in Tinnitus Patients

Role: lead

NCT00591994Not ApplicableCompleted

Tinnitus Treatment With Piribedil Guided by Acoustic Otoemissions and Electrocochleography

Role: lead

All 6 trials loaded